Multiple Sclerosis
Conference Coverage
Newest oral DMTs haven’t yet made a big impact in the MS world
“Now there are six oral DMTs competing among themselves for a relatively limited pool of patients.”
Conference Coverage
Constraint-induced movement therapy may boost neuroplasticity in MS
For patients with asymmetric upper limb nonuse, the treatment “is highly successful for promoting increased use by the more-affected arm.”
Conference Coverage
Telerehabilitation may be effective in MS
Patients with MS may achieve equivalent benefits and increased cost savings with telerehabilitation, compared with outpatient rehabilitation.
Conference Coverage
No benefit of three commonly used medications for MS fatigue
These findings will hopefully encourage doctors to “think twice before prescribing these medications that could be harmful and have no clear...
Conference Coverage
Ofatumumab shows high elimination of disease activity in MS
The once-per-month self-injected therapy could offer an alternative to DMTs that require in-office infusion.
Conference Coverage
Natalizumab switch to moderate-efficacy DMT increases disability risk
“Patients transitioning from natalizumab to another high-efficacy therapy have better inflammatory and disability outcomes, compared with those...
Conference Coverage
High levels of air pollution linked to increased MS risk
“Countermeasures that cut air pollution can be important for public health, not only to reduce deaths related to cardiac and pulmonary diseases...
Latest News
Neurologists’ pay gets a boost, most happy with career choice
Neurologists’ average annual income this year rose to $280,000, up from $267,000 last year.
Conference Coverage
Natalizumab bests fingolimod for relapsing-remitting MS
More patients taking natalizumab versus fingolimod reached NEDA at one year.
Literature Review
Satralizumab monotherapy reduces NMOSD relapse rate
The trial helps confirm role of interleukin-6 in the pathobiology of aquaporin-4 autoantibody seropositive disease.
Conference Coverage
Depression linked to neuro dysfunction, brain lesions in MS
“Depression isn’t just a neuropsychiatric disease,” said Dr. Jenny Feng.